• Pathophysiology
    • Low-grade B-cell lymphoma (lymphoplasmacytic) causing massive production of monoclonal IgM paraprotein.
    • Associated with MYD88 gene mutation.
    • Large size of IgM pentamers leads to hyperviscosity syndrome.
  • Clinical Features
    • Older adults. Often asymptomatic.
    • Hyperviscosity Syndrome: Blurry vision, headaches, dizziness, mucosal bleeding (nasal/gingival).
    • Constitutional “B” symptoms (fever, night sweats, weight loss).
    • Anemia (from marrow infiltration), peripheral neuropathy, hepatosplenomegaly.
  • Diagnostics
    • Serum Protein Electrophoresis (SPEP): IgM M-spike.
    • Bone marrow biopsy: >10% clonal lymphoplasmacytic cells.
  • Key Distinction from Multiple Myeloma
    • WM: IgM spike, hyperviscosity, NO lytic bone lesions, NO hypercalcemia.
    • MM: IgG or IgA spike, lytic bone lesions, hypercalcemia, renal failure.
  • Treatment
    • Asymptomatic: Observe.
    • Symptomatic/Hyperviscosity: Plasmapheresis (acute), followed by chemoimmunotherapy (e.g., Rituximab, BTK inhibitors like Ibrutinib).